Our long-term goal is to create genetic antimicrobials based on RNA devices delivered by phages. For this, we have also been engineering efficient gene delivery systems to transduce RNA devices into bacteria (see our P2 phage publication).
We work at the interface of experimental molecular biology, combinatorial optimisation, microfluidics and directed evolution. Joint us to create RNA-powered phages against pathogenic bacteria.
We are looking for strongly motivated and talented people willing to contribute developing a disruptive methodology to create new molecules and phages different to anything known ("de novo"). In particular, we aim to create a new generation of personalized antimicrobials based on synthetic phages and RNA devices.